Director, US Scientific Marketing – Melanoma

About   Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics , Inc.  is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The  Iovance TIL platform  spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit  www.iovance.com .

Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners.

Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on  www.iovance.com .

Overview

The Director of Scientific Marketing, Melanoma is a member of Iovance’s US Marketing Cell Therapy team, with accountability for developing the strategic direction for scientific strategy and medical education activities supporting AMTAGVI, the only FDA approved T Cell Therapy for Metastatic Melanoma. Primary focus will be on the Advanced Melanoma market but will evolve over time to support additional indications as pipeline programs mature.

The ideal candidate is someone with experience in metastatic melanoma or with prior Cell Therapy Scientific Marketing experience. The candidate needs to have an entrepreneurial spirit looking for an opportunity to be part of the first-in-class launch of an innovative cell therapy for metastatic melanoma. The Director of Scientific Marketing will report to the Head of Marketing.

Essential Functions and Responsibilities

The Scientific P2P & MedEd Marketing Lead will be responsible for the success of an expansive P2P education and promotion platform, encompassing speaker programs, clinical experience roundtables, advisory boards, and other activities.

This role requires senior level marketing expertise and strong strategic and analytical thinking as well as creativity and decision-making skills.

P2P (Peer-to-Peer) strategy, planning, and execution

Develop educational content consistent with overall brand strategy to drive impactful peer to peer engagements.

Lead national and regional peer to peer programming and execution, including development of speaker program materials and coordination with sales leads.

Partner with Medical Affairs to provide commercial perspective on publications, scientific communications, and real-world evidence/ HEOR data generation.

Ensure that all marketing activities are in compliance with regulatory and legal requirements.

Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics.

Perform miscellaneous duties as assigned.

Travel – 30%

Required Education, Skills, and Knowledge

12+ years of relevant marketing or related healthcare experience required.

A bachelor’s degree in marketing or related fields is required.

Knowledge of oncology drug development and understanding of melanoma disease

Demonstrated ability to own and execute commercial facing scientific marketing strategy in a resource-lean fast moving biotech environment.

Awareness of competitive dynamics, emerging science and trends within melanoma and immuno-oncology